Sunday, November 1, 2026

Back to today

From X

@calvinblissett 1 click

Calvin Blissett on X

$TBBK: $46.75, $1.91B mkt cap, 8.2x trailing earnings and ~6.6x the new 2027 guide ($7.00-7.20), a 36% ROE, and 11% fewer shares than a year ago. $200M of buybacks this year, about 10% of the market cap. The Bancorp is the bank behind a lot of the fintech cards in your wallet. Fintechs bring the customers and Bancorp holds the deposits, which cost it almost nothing. Q3 EPS was $1.53, up 30%, fintech fees grew 19%, and payment volume grew 23% to $54B. The stock still fell 7.5% Friday because they cut the 2027 target from $8.10-8.30 to $7.00-7.20. In September Chime agreed to buy Stride Bank, its other partner bank, and the market read that as Chime eventually leaving. The bears have been loud and sometimes right. A VIC short in Dec 2023 at $38.93 called the earnings unsustainable and the accounting aggressive. On X, one guy called the guide-down "easy to call" before it happened, and others flagged the small business lending exit, layoffs, and a lending head leaving with a $2.5M package. But since that short the share count has gone from 54M to 41M, and the stock is higher. Even on the reset numbers you're paying ~6.6x 2027 and ~5.8x their preliminary 2028, and they plan to buy back ~100% of net income from 2027 on. Value Line cut it to Technical 5 on Friday, so nobody wants it. The whole question is how much Chime volume leaves. Management calls the new 2027 number a baseline, so watch whether it holds.
@StableBread

Fajasy on X

The ~$120M of debt TOYO Co., Ltd $TOYO expects to use for its planned $357M Texas cell plant is still in “very early stage” talks. $TOYO plans a 1.5 GW heterojunction (HJT) cell plant co-located with the Humble, Texas module plant. HJT is a different cell design from the TOPCon cells $TOYO makes today, and $TOYO later wants to add a layer of perovskite (a second light-absorbing material) on top of its HJT cells to get more power per cell. More importantly, the plant would let $TOYO make most of the cells for its Texas panels in the U.S. instead of importing them from Ethiopia, and $TOYO’s Section 232 term sheet (its request for relief from the new 15% U.S. tariff on imported cells) is tied to the plant. $TOYO announced the plant on June 8 at a projected $357M, with pilot production “within 20 months.” By its October 6 Analyst Day, its domestic design was complete, permit applications were ongoing, civil construction was set to start only after all permits are obtained, and pilot production was targeted for Q1 2028. $TOYO plans to fund most of the plant with 45X tax credits (earned on each unit of solar equipment made in the U.S.) and debt. The 45X piece assumes the cell plant runs (cells earn $0.04/W), and the debt is, in the slide’s words, “in the planning stages; no definitive documentation has been signed yet.” CFO Yasunari Harada told analysts on October 6 that talks with Japanese and U.S. lenders were a “very early stage discussion.” As for timing, Rhone Resch, $TOYO’s Chief Strategy Officer, told a July 29 webinar audience $TOYO was “under construction” on the plant, and the August 19 results of its Japanese parent, Abalance, later put the construction start in April 2027 (planned), consistent with the Analyst Day plan to wait for all permits. So the Texas module plant is running and contracted into 2027, but the cell plant that would make $TOYO’s U.S. supply chain its own is still awaiting permits, with its $120M of debt in early talks.

Altria: Dutiful

Altria raised 2026 adjusted EPS guidance to $5.66 to $5.74 and authorized more buybacks, while on! loses share as cigarette margins hold.

When the liquidity does not add up

Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet…

Verra veerer

Verra Mobility’s Avis termination threatens 2027 earnings, while Government Solutions profit rose 25% and implied fourth-quarter guidance…

FTAI 3Q26: Aero margins in focus

FTAI’s Aerospace Products margin rebounded to 31% as CFM56 module output rose, while Power deposits and contracted deliveries fund its 2027…

T · short

At&t INC

AT&T’s stalled deleveraging and share repurchase case has prompted a bearish turn on the telecom stock.

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.